Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
F-TAF in Dried Blood Spots for Adherence Monitoring
NCT02962739Phase 1Completed
- Sponsor
- University of Colorado Denver
- Start
- Mar 2016
- Primary completion
- May 2019
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of tenofovir alafenamide in human immunodeficiency virus infection (HIV), sponsored by University of Colorado Denver. Started Mar 2016; status: completed.
02
Drugs
tenofovir alafenamide
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02962739.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962739.